Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fixed Dose Combination Tablets”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01975220
What this trial is testing

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets

Who this might be right for
Healthy
Boehringer Ingelheim 72
Early research (Phase 1)Study completedNCT02508168
What this trial is testing

Phase 1 Bioavailability Study of SYR-322MET

Who this might be right for
Healthy Volunteers
Takeda 24
Large-scale testing (Phase 3)Study completedNCT01533259
What this trial is testing

Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 48
Early research (Phase 1)Study completedNCT01192139
What this trial is testing

Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)

Who this might be right for
Diabetes Mellitus
AstraZeneca 30
Post-approval studies (Phase 4)UnknownNCT00216333
What this trial is testing

Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
International Union Against Tuberculosis and Lung Diseases 1,500
Large-scale testing (Phase 3)Study completedNCT00323544
What this trial is testing

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Who this might be right for
HIV Infections
Gilead Sciences 220
Testing effectiveness (Phase 2)Study completedNCT01958281
What this trial is testing

Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency

Who this might be right for
HCV Infection
Gilead Sciences 38
Not applicableStudy completedNCT05337969
What this trial is testing

The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed.

Who this might be right for
To Determine Bioequivalence Under Fed Conditions
AET Laboratories Private Limited 60
Early research (Phase 1)Study completedNCT03138356
What this trial is testing

Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 126
Early research (Phase 1)Study completedNCT01068743
What this trial is testing

Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 24
Early research (Phase 1)Study completedNCT01002807
What this trial is testing

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
AstraZeneca 15
Early research (Phase 1)Study completedNCT00929201
What this trial is testing

Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 61
Large-scale testing (Phase 3)Study completedNCT00053638
What this trial is testing

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

Who this might be right for
HIV Infection
GlaxoSmithKline 345
Not applicableStudy completedNCT01561976
What this trial is testing

Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 30
Post-approval studies (Phase 4)Study completedNCT00323492
What this trial is testing

TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada

Who this might be right for
HIV Infections
Gilead Sciences 92
Early research (Phase 1)Study completedNCT04322266
What this trial is testing

Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.

Who this might be right for
Healthy
Hanmi Pharmaceutical Company Limited 61
Large-scale testing (Phase 3)Study completedNCT00094367
What this trial is testing

A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)

Who this might be right for
HIV Infection
GlaxoSmithKline 900
Early research (Phase 1)Study completedNCT02121509
What this trial is testing

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 74
Early research (Phase 1)Study completedNCT05378906
What this trial is testing

Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 32
Early research (Phase 1)Study completedNCT02039245
What this trial is testing

Multiple Dose Pharmacokinetics of Canagliflozin/Metformin 150/1,000 mg Fixed Dose Combination

Who this might be right for
Healthy Volunteers
Janssen Research & Development, LLC 12
Next Page